Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. META
3. STZ
4. TSLA
5. FDS
6. HOOD
7. VEON
8. DOLE
9. LEVI
10. VANI

Go back to Mydecine Receives Conditional IRB Approval for Phase 2b Smoking Cessation Study
(NASDAQ: MYCO) Delayed: 24.37 --0 (-0%)
Previous Close $24.37    52 Week High $ 
Open $24.37    52 Week Low $ 
Day High $24.37    P/E N/A 
Day Low $24.37    EPS $ 
Volume 24,575       

(AMEX: MYCOF) Delayed: 2.00 --0 (-0%)
Previous Close $2.00    52 Week High $ 
Open $2.00    52 Week Low $ 
Day High $2.00    P/E N/A 
Day Low $2.00    EPS $ 
Volume 420